581 related articles for article (PubMed ID: 7929439)
1. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
[TBL] [Abstract][Full Text] [Related]
2. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
3. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
[TBL] [Abstract][Full Text] [Related]
4. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.
Wu LW; Mayo LD; Dunbar JD; Kessler KM; Baerwald MR; Jaffe EA; Wang D; Warren RS; Donner DB
J Biol Chem; 2000 Feb; 275(7):5096-103. PubMed ID: 10671553
[TBL] [Abstract][Full Text] [Related]
5. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
[TBL] [Abstract][Full Text] [Related]
6. Sck is expressed in endothelial cells and participates in vascular endothelial growth factor-induced signaling.
Ratcliffe KE; Tao Q; Yavuz B; Stoletov KV; Spring SC; Terman BI
Oncogene; 2002 Sep; 21(41):6307-16. PubMed ID: 12214271
[TBL] [Abstract][Full Text] [Related]
7. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor.
Terman B; Khandke L; Dougher-Vermazan M; Maglione D; Lassam NJ; Gospodarowicz D; Persico MG; Böhlen P; Eisinger M
Growth Factors; 1994; 11(3):187-95. PubMed ID: 7734144
[TBL] [Abstract][Full Text] [Related]
8. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
Tao Q; Backer MV; Backer JM; Terman BI
J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
[TBL] [Abstract][Full Text] [Related]
9. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
10. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
12. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells.
Kroll J; Waltenberger J
J Biol Chem; 1997 Dec; 272(51):32521-7. PubMed ID: 9405464
[TBL] [Abstract][Full Text] [Related]
13. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
[TBL] [Abstract][Full Text] [Related]
14. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF.
Wang D; Donner DB; Warren RS
J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050
[TBL] [Abstract][Full Text] [Related]
15. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
Chou MT; Wang J; Fujita DJ
BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
[TBL] [Abstract][Full Text] [Related]
16. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
17. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
Suzuma K; Naruse K; Suzuma I; Takahara N; Ueki K; Aiello LP; King GL
J Biol Chem; 2000 Dec; 275(52):40725-31. PubMed ID: 11018037
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
Gerber HP; McMurtrey A; Kowalski J; Yan M; Keyt BA; Dixit V; Ferrara N
J Biol Chem; 1998 Nov; 273(46):30336-43. PubMed ID: 9804796
[TBL] [Abstract][Full Text] [Related]
20. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
